{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "As laws are eased, some users find that the high leads only to a cliff.", "headline": {"seo": "As Marijuana Laws Ease, the Risks Grow", "main": "Candy\u2019s Dandy, but Pot\u2019s Scary", "kicker": "Op-Ed | T. M. Luhrmann", "print_headline": "Candy\u2019s Dandy, but Pot\u2019s Scary", "content_kicker": "Contributing Op-Ed Writer"}, "abstract": "T M Luhrmann Op-Ed article warns that marijuana is more dangerous than commonly thought; points to research drawing link between marijuana use and schizophrenia; argues that behavior under influence of drugs is heavily influenced by cultural expectations, and expresses hope that violence associated with alcohol use in America does not migrate to marijuana use.", "print_page": null, "word_count": "750", "_id": "53a4c2007988103d0e80b108", "snippet": "As laws are eased, some users find that the high leads only to a cliff.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/21/opinion/tm-luhrmann-as-marijuana-laws-ease-the-risks-grow.html", "multimedia": [{"subtype": "wide", "url": "images/2013/04/05/opinion/tanya-lurmann/tanya-lurmann-thumbWide-v3.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/04/05/opinion/tanya-lurmann/tanya-lurmann-thumbWide-v3.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/04/05/opinion/tanya-lurmann/tanya-lurmann-articleLarge-v3.jpg", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/04/05/opinion/tanya-lurmann/tanya-lurmann-articleLarge-v3.jpg", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/04/05/opinion/tanya-lurmann/tanya-lurmann-thumbStandard-v2.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/04/05/opinion/tanya-lurmann/tanya-lurmann-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Marijuana", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Schizophrenia", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Social Conditions and Trends", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "United States", "is_major": "Y", "rank": "6", "name": "glocations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "T."}], "original": "By T. M. LUHRMANN"}, "document_type": "article", "pub_date": "2014-06-21T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "More health prescription plans are refusing to cover certain drugs unless the companies charge less for them.", "headline": {"main": "Health Insurers Pressing Down on Drug Prices", "print_headline": "Health Insurers Are Pushing Back on Drug Prices"}, "abstract": "Analysts at Credit Suisse estimate that collective discounts and rebates for 15 large drug companies amounted to 31.9 percent of gross United States sales in 2013, up from 30.2 percent in 2012 and 19.7 percent in 2007; change reflects how health prescription plans are refusing to cover certain drugs unless companies charge less for them, which appears to be forcing pharmaceutical makers to compete on price.", "print_page": "1", "word_count": "1399", "_id": "53a47e397988103d0e80b006", "snippet": "More health prescription plans are refusing to cover certain drugs unless the companies charge less for them.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/21/business/health-plans-bring-pressure-to-bear-on-drug-prices.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/21/business/jp-prices/jp-prices-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/21/business/jp-prices/jp-prices-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/21/business/jp-prices/jp-prices-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/21/business/jp-prices/jp-prices-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/21/business/jp-prices/jp-prices-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/21/business/jp-prices/jp-prices-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Express Scripts Inc", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Novo Nordisk A/S", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Health Insurance and Managed Care", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "AbbVie Inc", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "GlaxoSmithKline PLC", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "CVS Caremark Corporation", "is_major": "N", "rank": "4", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-06-21T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Business", "lead_paragraph": null, "headline": {"main": "Drug Maker AbbVie Joins a Stampede to Go Abroad", "kicker": "DealBook", "print_headline": "AbbVie Joins a Stampede to Go Abroad"}, "abstract": "An American drug company\u2019s yet-unsuccessful attempts to purchase an Irish competitor make it the latest company to try to relocate through buyouts to a country with lower tax rates.", "print_page": null, "word_count": "1011", "_id": "53a402877988106a6836c569", "snippet": "An American drug company\u2019s yet-unsuccessful attempts to purchase an Irish competitor make it the latest company to try to relocate through buyouts to a country with lower tax rates.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dealbook.nytimes.com/2014/06/20/drug-maker-shire-rejects-offer-from-abbvie-worth-about-46-billion/", "multimedia": [{"subtype": "wide", "url": "images/2014/06/24/business/dbpix-drug1/dbpix-drug1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/24/business/dbpix-drug1/dbpix-drug1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/24/business/dbpix-drug1/dbpix-drug1-articleLarge.jpg", "height": 272, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/24/business/dbpix-drug1/dbpix-drug1-articleLarge.jpg", "xlargeheight": "272"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/24/business/dbpix-drug1/dbpix-drug1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/24/business/dbpix-drug1/dbpix-drug1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Dealbook", "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Shire PLC", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "AbbVie Inc", "is_major": "Y", "rank": "1", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "David", "lastname": "GELLES"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Chad", "lastname": "BRAY"}], "original": "By DAVID GELLES and CHAD BRAY"}, "document_type": "blogpost", "pub_date": "2014-06-20T05:43:01Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Doctors in Ohio have developed a simple four-page quiz that can help reveal dementia early on, allowing patients to get their lives in order.", "headline": {"main": "A Test for the Early Detection of Alzheimer\u2019s Disease", "kicker": "Your Money Adviser", "content_kicker": "Your Money"}, "abstract": null, "print_page": "", "word_count": "1057", "_id": "53a35d697988106a6836c3d6", "snippet": "Doctors in Ohio have developed a simple four-page quiz that can help reveal dementia early on, allowing patients to get their lives in order.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/20/your-money/a-test-for-the-early-detection-of-alzheimers-disease.html", "multimedia": [], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Alzheimer's Disease", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Tests (Medical)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Elderly", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Ann", "rank": 1, "lastname": "CARRNS"}], "original": "By ANN CARRNS"}, "document_type": "article", "pub_date": "2014-06-20T00:00:00Z", "section_name": "Your Money"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Two major studies identified mutations in a single gene that keep down levels of triglycerides, a discovery that prompted hopes for a new class of drugs.", "headline": {"main": "In Single Gene, a Path to Fight Heart Attacks", "print_headline": "In Single Gene, a Path to Fight Heart Attacks"}, "abstract": "Two studies independently identify mutations in a single gene that protect against heart attacks by keeping levels of triglycerides, confirmed as a cause of heart disease, very low for a lifetime; discovery, published in The New England Journal of Medicine, prompts hopes for a new class of drugs to fight heart disease.", "print_page": "1", "word_count": "1284", "_id": "53a1ff277988101bf370b8f5", "snippet": "Two major studies identified mutations in a single gene that keep down levels of triglycerides, a discovery that prompted hopes for a new class of drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/19/health/scientists-identify-mutations-that-protect-against-heart-attacks.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/19/us/JP-HEART/JP-HEART-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/19/us/JP-HEART/JP-HEART-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/19/us/JP-HEART/JP-HEART-articleLarge.jpg", "height": 395, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/19/us/JP-HEART/JP-HEART-articleLarge.jpg", "xlargeheight": "395"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/19/us/JP-HEART/JP-HEART-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/19/us/JP-HEART/JP-HEART-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "University of Maryland", "is_major": "N", "rank": "11", "name": "organizations"}, {"value": "Amish", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Massachusetts General Hospital", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Kathiresan, Sekar", "is_major": "N", "rank": "7", "name": "persons"}, {"value": "Tybjaerg-Hansen, Anne", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Heart", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Copenhagen University Hospital", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "New England Journal of Medicine", "is_major": "Y", "rank": "10", "name": "organizations"}, {"value": "Triglycerides", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2014-06-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "", "headline": {"main": "Is a Pill Enough to Fight H.I.V.?", "kicker": "Room For Debate"}, "abstract": "Is promoting the use of the antiviral drug Truvada a good public health strategy, or will it encourage more to have unprotected sex?", "print_page": null, "word_count": "1762", "_id": "53a0e0607988104e484b6274", "snippet": "Is promoting the use of the antiviral drug Truvada a good public health strategy, or will it encourage more to have unprotected sex?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/roomfordebate/2014/06/17/is-prep-a-good-way-to-fight-hiv-infections/", "multimedia": [], "subsection_name": "Room For Debate", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2014-06-17T19:08:20Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "The feisty chief of Allergan, Botox\u2019s maker, says a takeover would imperil the company\u2019s drug-discovery mission.", "headline": {"main": "Allergan, Defending Its Fort Botox", "print_headline": "The Defense of Fort Botox"}, "abstract": "Allergan, creator of Botox, has waged a fierce battle to fend off takeover attempt from Valeant Pharmaceuticals; chief executive David E I Pyott has led charge, arguing to shareholders that a merger would undermine company's drug-development and marketing acumen.", "print_page": "1", "word_count": "1409", "_id": "539c55727988103b24442ebe", "snippet": "The feisty chief of Allergan, Botox\u2019s maker, says a takeover would imperil the company\u2019s drug-discovery mission.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/15/business/allergan-defending-its-fort-botox.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/15/business/15-BOTOX/15-BOTOX-articleLarge.jpg", "height": 544, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/15/business/15-BOTOX/15-BOTOX-articleLarge.jpg", "xlargeheight": "544"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Allergan Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Botox (Drug)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Inventions and Patents", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Pyott, David E I", "is_major": "Y", "rank": "6", "name": "persons"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "7", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Natasha", "lastname": "SINGER"}], "original": "By NATASHA SINGER"}, "document_type": "article", "pub_date": "2014-06-15T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 7, "offset": 0, "time": 247}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}